McKesson Corporation (MCK) : Mondays money flow data in McKesson Corporation (MCK) suggests that the bulls made the most of the weakness in the stock. The inflow of money into the stock on upticks was $29.17 million, whereas, $27.51 million worth of transactions were done on downticks. The ratio between the two, uptick and downtick stood at 1.06, in favor of the bulls. The total money flow into the stock was $1.65 million clearly indicating that the smart money has been buying into the stock on weakness.
In comparison, the money flow in block deals was $2.31 million. The total value of block trades done on upticks was $4.83 million. The value of bearish trades on downticks was only $2.52 million.The up/down ratio in the block trades was a healthy 1.92 in favor of the bulls, suggesting strong buying in the stock by large traders. McKesson Corporation (MCK) fell $0.11 and traded at $197.03, down -0.06% for the day, over previous days close. On a weekly basis, the shares are 2.2% over the previous weeks close.
McKesson Corporation is up 13.79% in the last 3-month period. Year-to-Date the stock performance stands at 0.57%. Shares of McKesson Corporation rose by 2.2% in the last five trading days and 9.99% for the last 4 weeks. In a related news,The officer (EVP & Chief Financial Officer) of Mckesson Corp, Beer James A sold 5,500 shares at $199 on July 14, 2016. The Insider selling transaction had a total value worth of $1,094,500. The Insider information was disclosed with the Securities and Exchange Commission in a Form 4 filing.
McKesson Corporation (NYSE:MCK): stock turned positive on Monday. Though the stock opened at $197.3, the bulls momentum made the stock top out at $197.93 level for the day. The stock recorded a low of $196.074 and closed the trading day at $197.7, in the green by 0.28%. The total traded volume for the day was 814,661. The stock had closed at $197.14 in the previous days trading.
McKesson Corporation (McKesson) is engaged in delivering pharmaceuticals, medical supplies and healthcare information technology. The Company operates through two business segments: McKesson Distribution Solutions and Technology Solutions. The McKesson Distribution Solutions segment distributes drugs and equipment, and health and beauty care products across North America and internationally. The Distribution Solutions segment provides pharmaceutical solutions for biotech and pharmaceutical manufacturers, and practice management, technology, clinical support and business solutions to oncology and other specialty practices operating in the community setting. The Technology Solutions segment delivers clinical, patient care, financial, supply chain and strategic management software solutions, as well as connectivity, outsourcing and other services, including remote hosting and managed services, to healthcare organizations.